Percutaneous Coronary Intervention in Diabetic Patients
Cardiovascular disease (CVD) is responsible for 30% of deaths worldwide and is the leading cause of premature mortality in patients with diabetes mellitus (DM). One of the main contributors to the increased atherothrombotic risk in DM patients relates to their pro- inflammatory and prothrombotic sta...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/74052 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Percutaneous Coronary Intervention in Diabetic Patients
- Pharmacotherapy During Percutaneous Coronary Interventions
- Gender Differences in Clinical Outcomes of Patients with Coronary Artery Disease after Percutaneous Coronary Intervention
- Is Coronary Artery Bypass Grafting (CABG) Surgery Still Preferable to Percutaneous Coronary Intervention (PCI) in View of Long-Term Outcomes among Diabetic Patients?
- The Role of Exercise Test After Percutaneous Coronary Intervention
- Multivessel Disease in the Modern Era of Percutaneous Coronary Intervention
- Myocardial Perfusion Imaging in Diagnosis of Culprit Lesion in Patients Undergoing Elective Percutaneous Coronary Intervention